ArticleThe Lancet. Public health2024
Nitazenes-heralding a second wave for the UK drug-related death crisis?
Abstract read
In one paragraph
Article in The Lancet. Public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed.
- A heroin overdose laboratory model: How do escalating doses of diamorphine alter respiratory function in a diamorphine-treated population?Addiction (Abingdon, England) · 2025Trial
- Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs.Current pain and headache reports · 2026Review
- Price of Nitazenes for Sale on Cryptomarkets and Surface Web Shops.Drug and alcohol review · 2026Article
- Molecular mechanism of allosteric modulation of opioid receptors.Signal transduction and targeted therapy · 2026Article
- Emergence of synthetic drugs in South America: insights from Brazil, Chile, and Colombia.Harm reduction journal · 2026Review
- Slow Dissociation of Nitazenes from thebioRxiv : the preprint server for biology · 2026Article
- Article
- Attitudes to Drug Policy in Australia, 2001-2022/23: What Does This Mean for Drug Policy Reform in Australia?Drug and alcohol review · 2026Article
- Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999-2024: An update report to inform the reclassification debate.Journal of psychopharmacology (Oxford, England) · 2026Article
- Computational design of dynamic biosensors for emerging synthetic opioids.Nature communications · 2026Article
- A qualitative study of the impacts of a government crackdown against revenue sharing between pharmacies and patients in Vancouver, Canada.Discover public health · 2026Article
- Peer research with populations of people who use street tablets in areas over-represented by drug-related harms in the UK: a case study.Harm reduction journal · 2025Article
- The nitazene epidemic in Estonia: a first report.European journal of public health · 2025Article
- Awareness of drug supply changes and uptake of fentanyl testing services among people who use drugs in Kampala, Uganda.Drug and alcohol dependence · 2025Article
- Effectiveness, acceptability, and feasibility of naloxone in carceral settings: a scoping review.Harm reduction journal · 2025Article
- Reversing the triad of anaesthesia in a cannot intubate, cannot oxygenate emergency. Comment on Br J Anaesth 2024; 133: 190-2.British journal of anaesthesia · 2025Article
- Membrane Permeability Drives the Extreme Potency of Fentanyl but not Isotonitazene.bioRxiv : the preprint server for biology · 2025Article
- Nitazenes: The Emergence of a Potent Synthetic Opioid Threat.Molecules (Basel, Switzerland) · 2025Review
- Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples.Harm reduction journal · 2025Article
- Field-Portable Technology for Illicit Drug Discrimination via Deep Learning of Hybridized Reflectance/Fluorescence Spectroscopic Fingerprints.Analytical chemistry · 2025Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Adam HollandFaculty of Public Health Drugs Special Interest Group, London, UK; School of Psychological Science, University of Bristol, Bristol BS8 2BN, UK; School of Population Health Sciences, University of Bristol, Bristol BS8 2BN, UK; Department of Public Health, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: adam.holland@bristol.ac.uk.
Caroline S CopelandInstitute of Pharmaceutical Science, King's College London, London, UK; National Programme on Substance Abuse Deaths, King's College London, London, UK.
Gillian W ShorterFaculty of Public Health Drugs Special Interest Group, London, UK; Drug and Alcohol Research Network, School of Psychology, Queen's University Belfast, Belfast, UK.
Dean J ConnollyFaculty of Public Health Drugs Special Interest Group, London, UK; Department of Public Health, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Alice WisemanFaculty of Public Health Drugs Special Interest Group, London, UK; Association of Directors of Public Health, London, UK.
John MooneyFaculty of Public Health Drugs Special Interest Group, London, UK; Public Health Directorate, NHS Grampian, Aberdeen, UK; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Kevin FentonFaculty of Public Health, London, UK.
Magdalena HarrisFaculty of Public Health Drugs Special Interest Group, London, UK; Department of Public Health, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Funding
Medical Research Council MR/X018636/1
Abstract
PubMed holds no abstract for this paper.
Indexed as
BenzimidazolesDrug OverdoseHumansUnited KingdomBenzimidazoles
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.